Emerging strategies and options: Difference between revisions
From MalariaETC
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
<span style="font-size:90%">'''Multiplexed detection strategies''' may be used in some circumstances to optimase performance for local need:</br></br> (a) Where both ''P.falciparum'' and ''P.vivax'' are highly prevalent, then tests with specificity for each species may prove valuable - ''P.falciparum'' (HRP2) and ''P.vivax'' (Pv-pLDH) may be combined with or without a pen-specific antibody. This can offer some advantages in detecting dual infection by the two species.</br></br>(b) Where HRP2 deletion are frequent, they may cause a high risk for test failure, tests multiplexed to select for Pf-pLDH and HRP2 may improve detection in these circumstances. | <span style="font-size:90%">'''Multiplexed detection strategies''' may be used in some circumstances to optimase performance for local need:</br></br> (a) Where both ''P.falciparum'' and ''P.vivax'' are highly prevalent, then tests with specificity for each species may prove valuable - ''P.falciparum'' (HRP2) and ''P.vivax'' (Pv-pLDH) may be combined with or without a pen-specific antibody. This can offer some advantages in detecting dual infection by the two species.</br></br>(b) Where HRP2 deletion are frequent, they may cause a high risk for test failure, tests multiplexed to select for Pf-pLDH and HRP2 may improve detection in these circumstances. | ||
---- | |||
[[Rapid diagnostic tests (RDTs)|Back to previous page]] | <span style="font-size:90%">[[Rapid diagnostic tests (RDTs)|Back to previous page]]</span> | ||
Revision as of 08:55, 27 September 2024
| Emerging Strategies
|